LOGAN PHARMACEUTICALS LIMITED


Director	MOHAMMED, Ahdul Farooq


Registered Address	77 Dunn Street
	Glasgow
	G40 3PA


Registered Number	SC447506 (Scotland)

Balance Sheet as at
31 August 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Tangible assets	3		204,586		207,679
			204,586		207,679
Current assets
Stocks	4	187,803		100,453
Debtors	5	456,074		276,211
Cash at bank and on hand		826,738		209,599
		1,470,615		586,263
Creditors amounts falling due within one year	6	(988,702)		(403,254)
Net current assets (liabilities)			481,913		183,009
Total assets less current liabilities			686,499		390,688
Net assets			686,499		390,688
Capital and reserves
Called up share capital			1		1
Profit and loss account			686,498		390,687
Shareholders' funds			686,499		390,688

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 29 May 2026, and are signed on its behalf by:

MOHAMMED, Ahdul Farooq
Director
Registered Company No. SC447506

LOGAN PHARMACEUTICALS LIMITED

Notes to the Financial Statements
for the year ended 31 August 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

	Revenue from sale of goods
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue from sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Employee benefits
	Contributions to defined contribution plans are expensed in the period to which they relate.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Deferred tax
	Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Tangible fixed assets and depreciation
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

	Stocks and work in progress
	Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.

Stocks and work in progress

Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss.

Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	6		7

3.	Tangible fixed assets

	Land & buildings	Plant & machinery	Vehicles	Fixtures & fittings	Office Equipment	Total
	£	£	£	£	£	£
Cost or valuation
At 01 September 24	154,638	44,772	67,620	69,250	7,488	343,768
Additions	4,578	-	-	-	6,759	11,337
Disposals	-	-	-	-	(299)	(299)
At 31 August 25	159,216	44,772	67,620	69,250	13,948	354,806
Depreciation and impairment
At 01 September 24	-	24,838	55,344	53,142	2,765	136,089
Charge for year	-	4,984	3,069	4,026	2,114	14,193
On disposals	-	-	-	-	(62)	(62)
At 31 August 25	-	29,822	58,413	57,168	4,817	150,220
Net book value
At 31 August 25	159,216	14,950	9,207	12,082	9,131	204,586
At 31 August 24	154,638	19,934	12,276	16,108	4,723	207,679

4.	Stocks

	2025	2024
	£	£
Work in progress	187,803	100,453
Total	187,803	100,453

5.	Debtors: amounts due within one year

	2025	2024
	£	£
Trade debtors / trade receivables	154,228	139,664
Amounts owed by group undertakings	105,835	20,690
Other debtors	195,366	115,729
Prepayments and accrued income	645	128
Total	456,074	276,211

6.	Creditors: amounts due within one year

	2025	2024
	£	£
Trade creditors / trade payables	660,643	242,647
Amounts owed to related parties	48,364	67,642
Taxation and social security	182,642	55,149
Other creditors	21,868	34,216
Accrued liabilities and deferred income	75,185	3,600
Total	988,702	403,254

7.	Directors advances, credits and guarantees
	Directors current account balance is NIL (2024: £817 Cr).

8.	Related party transactions
	Group undertakings balance of £48,364 Cr (2024: £67,642 Cr) relates to Logan Healthcare Limited. This company is a wholly owned subsidiary of the parent Logan Holdings Company Limited. Debtors includes balance of £105,834 related to Logan Holdings company limited.